Connection

Perry Halushka to Bridged Bicyclo Compounds, Heterocyclic

This is a "connection" page, showing publications Perry Halushka has written about Bridged Bicyclo Compounds, Heterocyclic.
  1. Thromboxane A2 receptor density increases during chronic exposure to thromboxane A2 receptor antagonists after porcine carotid bypass. Cardiovasc Surg. 1997 Feb; 5(1):92-8.
    View in: PubMed
    Score: 0.134
  2. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation. 1995 Jun 01; 91(11):2742-7.
    View in: PubMed
    Score: 0.120
  3. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine. Biochem Pharmacol. 1995 Mar 30; 49(7):921-7.
    View in: PubMed
    Score: 0.118
  4. Sex steroid regulation of thromboxane A2 receptors in cultured rat aortic smooth muscle cells. Prostaglandins. 1995 Mar; 49(3):183-96.
    View in: PubMed
    Score: 0.118
  5. Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol. 1994 Sep; 267(3 Pt 2):H887-93.
    View in: PubMed
    Score: 0.114
  6. Characterization of human peripheral blood monocyte thromboxane A2 receptors. J Pharmacol Exp Ther. 1994 Aug; 270(2):446-52.
    View in: PubMed
    Score: 0.113
  7. Thromboxane A2 receptors in equine monocytes: identification of a new subclass of TXA2 receptors. J Leukoc Biol. 1993 Feb; 53(2):173-8.
    View in: PubMed
    Score: 0.102
  8. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1992 Aug; 262(2):632-7.
    View in: PubMed
    Score: 0.098
  9. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1992 Jul; 262(1):238-45.
    View in: PubMed
    Score: 0.098
  10. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets. J Biol Chem. 1991 Jul 25; 266(21):13752-8.
    View in: PubMed
    Score: 0.092
  11. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat. Biochem Pharmacol. 1991 Jul 15; 42(3):537-44.
    View in: PubMed
    Score: 0.091
  12. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP. Adv Prostaglandin Thromboxane Leukot Res. 1991; 21A:331-7.
    View in: PubMed
    Score: 0.088
  13. Thromboxane A2 receptors are influenced by cell density in cultured rat aortic smooth muscle cells. Life Sci. 1991; 48(25):2391-5.
    View in: PubMed
    Score: 0.088
  14. I-BOP, the most potent radiolabelled agonist for the TXA2/PGH2 receptor. Adv Prostaglandin Thromboxane Leukot Res. 1990; 20:102-9.
    View in: PubMed
    Score: 0.082
  15. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist. J Pharmacol Exp Ther. 1989 Nov; 251(2):557-62.
    View in: PubMed
    Score: 0.081
  16. Changes in vascular responsiveness to a thromboxane mimetic in endotoxin tolerance. Shock. 2001 Nov; 16(5):389-92.
    View in: PubMed
    Score: 0.047
  17. Coupling of thromboxane A2 receptor isoforms to Galpha13: effects on ligand binding and signalling. Biochim Biophys Acta. 1999 Jul 08; 1450(3):288-96.
    View in: PubMed
    Score: 0.040
  18. Modification on ligand binding to TXA2/PGH2 receptors by diethylpyrocarbonate. Adv Exp Med Biol. 1997; 400A:235-40.
    View in: PubMed
    Score: 0.033
  19. Inhibition of testosterone 5 alpha-reductase: evidence for tissue-specific regulation of thromboxane A2 receptors. J Pharmacol Exp Ther. 1996 Dec; 279(3):1386-91.
    View in: PubMed
    Score: 0.033
  20. Characterization of the cloned HEL cell thromboxane A2 receptor: evidence that the affinity state can be altered by G alpha 13 and G alpha q. J Pharmacol Exp Ther. 1996 May; 277(2):1132-9.
    View in: PubMed
    Score: 0.032
  21. Androstenedione increases thromboxane A2 receptors in human erythroleukemia cells. Life Sci. 1996; 58(8):683-90.
    View in: PubMed
    Score: 0.031
  22. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. J Pharmacol Exp Ther. 1994 Sep; 270(3):1192-6.
    View in: PubMed
    Score: 0.028
  23. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors. Biochim Biophys Acta. 1994 Mar 10; 1221(1):83-8.
    View in: PubMed
    Score: 0.027
  24. Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets. Eur J Pharmacol. 1992 Sep 01; 227(1):71-8.
    View in: PubMed
    Score: 0.025
  25. Characterization of the vascular thromboxane A2/prostaglandin endoperoxide receptor in rabbit aorta. Regulation by dexamethasone. Circ Res. 1990 Dec; 67(6):1562-9.
    View in: PubMed
    Score: 0.022
  26. Human platelets modulate edema formation in isolated rabbit lungs. J Clin Invest. 1989 Sep; 84(3):757-64.
    View in: PubMed
    Score: 0.020
  27. Hydrogen bond interactions of a series of N-substituted TXA2 receptor antagonists. Eur J Med Chem. 2003 Nov-Dec; 38(11-12):1015-24.
    View in: PubMed
    Score: 0.013
  28. The thromboxane receptor antagonist PBT-3, a hepoxilin stable analog, selectively antagonizes the TPalpha isoform in transfected COS-7 cells. J Pharmacol Exp Ther. 2003 Dec; 307(3):1142-7.
    View in: PubMed
    Score: 0.013
  29. Potentiation of PDGF-induced growth responses in coronary artery smooth muscle cells by thromboxane. Agents Actions Suppl. 1995; 45:53-8.
    View in: PubMed
    Score: 0.007
  30. Polymyxin B increases TXA2/PGH2 agonist and antagonist affinities in human platelet membranes. Eicosanoids. 1988; 1(1):41-4.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.